|
FREQUENTLY
ASKED QUESTIONS:
Who needs the services of The
Privacy Board?
Anyone conducting research
involving identifiable health information, regardless
of funding source or sponsorship, is subject to the
provisions of the Privacy Rule. If it will not be feasible
to obtain an Authorization, or the consent, of the individuals
whose health information you will be using or disclosing,
you may need the services of The Privacy Board in order
to have the Authorization requirement waived under HIPAA.
I have a local IRB, can I still
use The Privacy Board?
Yes. However, if your
institution's policies require you to use the institution's
IRB or Privacy Board, then you should comply with those
policies.
Will a Waiver of Authorization
from The Privacy Board satisfy a Covered Entity's (CE)
concern that the information requested for the research
meets the criteria for "minimum necessary"
for the research purposes?
Yes. According to HHS,
the Privacy Rule (at 45 CFR 164.512(i)) permits a Covered
Entity to rely on the representations of a Privacy Board
that the information requested is the minimum necessary
for the research purpose. This is true regardless of
whether the documentation is obtained from an external
Privacy Board or one that is associated with the Covered
Entity.
Do I need to get Authorization
or Request a Waiver of Authorization in order to use
PHI to contact individuals to see if they are interested
in participating in a clinical trial?
That depends. According
to HHS, under the rule, a Covered Entity is permitted
to disclose protected health information to the individual
who is the subject of the information, regardless of
the purpose of the disclosure. Therefore, covered health
care providers and patients may continue to discuss
the option of enrolling in a clinical trial without
patient authorization, and without an IRB or Privacy
Board Waiver of Authorization.
However, where a Covered Entity wants to disclose an
individual's information to a third party for purposes
of recruitment in a research study, the CE first must
obtain either Authorization from the individuals or
a Waiver of Authorization from an IRB or Privacy Board.
I have studies that began
before April 14, 2003 and will continue afterward. Do
I need to have subjects sign new consent forms that
include HIPAA Authorization language or a separate Authorization?
No. According to the
regulations at 164.532(b), which address the effectiveness
of prior consents and authorizations, Covered Entity
may continue to use or disclose protected health information
pursuant to a consent, authorization, or other express
legal permission obtained from an individual permitting
the use or disclosure of protected health information
that does not comply with 164.506 or 164.508 of this
subpart consistent with paragraph (b) of this section.
In the
case of a consent, authorization, or other express
legal permission obtained from an individual that
identifies a specific research project that includes
treatment of individuals:
(i)
If the consent, authorization, or other express
legal permission obtained from an individual specifically
permits a use or disclosure for purposes of the
project, the Covered Entity may, with respect to
protected health information that it created or
received either before or after the applicable compliance
date of this subpart and to which the consent or
authorization applies, make such use or disclosure
for purposes of that project, provided that the
Covered Entity complies with all limitations placed
by the consent, authorization, or other express
legal permission obtained from an individual.
In order to ensure compliance
with HIPAA regulations, investigators and IRBs should
do the following now:
- Set a date after which all new projects will include
HIPAA compliant consent forms or authorization.
- Have the IRB amend the consent
form to include Authorization language at the time
of continuing review and renewal.
- Establish procedures to include
the authorization in the consent form or as an addendum
either at the time of renewal or when there is a revision
to the consent form.
- Subjects enrolled after April 14, 2003 should sign
HIPAA compliant consents or authorizations.
Who do I contact with questions?
If you have questions regarding
research and HIPAA or The Privacy Board submissions please
e-mail Jim
Saunders or call 781-431-7577.
What is the fee for using
The Privacy Board?
Please contact Jim
Saunders for information regarding fees.
|